Developing an evidence‐based ketogenic therapy program

Ketogenic diet in cancer therapy

An Archaeological Critique of Evidencebased Management: One Digression After Another

Fundamental problems remain with evidence-based management. We argue that, rather than being addressed, these problems are treated as digressions. One explanation for this is an ongoing incoherence: the evidence-based approach relegates narrative to a ghetto category of knowledge, but it is itself a narrative. Moreover, while this narrative is becoming more polished through repetition and selec...

Medium-chain triglyceride (MCT) ketogenic therapy.

The medium-chain triglyceride diet (MCTD) is a variant of the classic 4:1 ketogenic diet (KD) introduced in 1971 by Huttenlocher as an attempt to improve the palatability of the KD by allowing more carbohydrates yet preserving ketosis. Although initially found to be equally effective as the classic KD, use of the MCTD declined because of frequent gastrointestinal side effects such as cramps, di...

Developing an effective generic prescription drug program.

Pharmacy benefit managers (PBMs) use a variety of pricing strategies. When employers have a thorough knowledge of those strategies, they can use them to their advantage to help manage pharmacy benefits. This article discusses PBM strategies in terms of what employers need to know, the questions employers need to ask and goals employers must keep in mind in order to secure the affordable cost an...

An Outpatient Physical Therapy Intervention Program